|
x |
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
|
o |
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
ACT
|
Argan,
Inc.
|
(Exact
Name of registrant as Specified in Its
Charter)
|
Delaware
|
13-1947195
|
(State
or other Jurisdiction of Incorporation
or
Organization)
|
(I.R.S.
Employer Identification No.)
|
One
Church Street, Suite 401, Rockville MD
20850
|
(Address
of Principal Executive Offices) (Zip
Code)
|
(301)
315-0027
|
(Registrant’s
telephone number, including area
code)
|
____________________________________
|
(Former
Name, Former Address and Former Fiscal Year,
if
Changed Since Last Report)
|
Large
accelerated filer o
|
Accelerated
filer o
|
Non-accelerated
filer þ
|
Page
No.
|
||||
PART I. |
FINANCIAL
INFORMATION
|
3
|
||
Item
1.
|
Financial
Statements (unaudited)
|
3
|
||
Condensed
Consolidated Balance Sheets - July 31, 2007 and January 31,
2007
|
3
|
|||
Condensed
Consolidated Statements of Operations for the Three and Six Months
Ended
July 31, 2007 and 2006
|
4
|
|||
|
||||
Condensed
Consolidated Statements of Cash Flows for the Six Months Ended
July 31, 2007 and 2006
|
5
|
|||
|
||||
Notes
to Condensed Consolidated Financial Statements
|
6
|
|||
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and
Results of Operation
|
15
|
||
Item
3.
|
Quantitative
and Qualitative Disclosures about Market Risk
|
27
|
||
Item
4.
|
Controls
and Procedures
|
27
|
||
PART II. |
OTHER
INFORMATION
|
27
|
||
Item
1.
|
Legal
Proceedings
|
27
|
||
Item
1a.
|
Risk
Factors
|
28
|
||
Item
2.
|
Unregistered
Sales of Equity Securities and Use of Proceeds
|
28
|
||
Item
3.
|
Defaults
Upon Senior Securities
|
28
|
||
Item
4.
|
Submission
of Matters to a Vote of Security Holders
|
28
|
||
Item
5.
|
Other
Information
|
29
|
||
Item
6.
|
Exhibits
|
29
|
||
SIGNATURES
|
30
|
July
31,
|
January
31,
|
||||||
2007
|
2007
|
||||||
ASSETS
|
|||||||
CURRENT
ASSETS:
|
|||||||
Cash
and cash equivalents
|
$
|
49,140,000
|
$
|
25,393,000
|
|||
Accounts
receivable, net of allowance for doubtful accounts of
$88,000
|
|||||||
at
7/31/07 and $137,000 at 1/31/2007
|
30,397,000
|
23,030,000
|
|||||
Receivable
from affiliated entity
|
-
|
155,000
|
|||||
Investments
available for sale
|
-
|
2,283,000
|
|||||
Escrowed
cash
|
15,034,000
|
15,031,000
|
|||||
Estimated
earnings in excess of billings
|
3,919,000
|
12,003,000
|
|||||
Current
deferred tax asset
|
435,000
|
-
|
|||||
Inventories,
net of reserves of $143,000 at 07/31/2007 and $104,000
|
|||||||
at
01/31/2007
|
2,442,000
|
2,387,000
|
|||||
Prepaid
expenses and other current assets
|
1,512,000
|
643,000
|
|||||
TOTAL
CURRENT ASSETS
|
102,879,000
|
80,925,000
|
|||||
Property
and equipment, net of accumulated depreciation of
|
|||||||
$2,922,000
at 7/31/2007 and $2,379,000 at 1/31/2007
|
2,887,000
|
3,250,000
|
|||||
Other
assets
|
235,000
|
313,000
|
|||||
Goodwill
|
23,981,000
|
23,981,000
|
|||||
Other
intangible assets, net
|
8,572,000
|
12,661,000
|
|||||
TOTAL
ASSETS
|
$
|
138,554,000
|
$
|
121,130,000
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
CURRENT
LIABILITIES:
|
|||||||
Accounts
payable
|
$
|
33,020,000
|
$
|
44,248,000
|
|||
Due
to affiliates
|
-
|
7,000
|
|||||
Accrued
expenses
|
6,794,000
|
5,873,000
|
|||||
Estimated
loss on uncompleted contracts
|
74,000
|
-
|
|||||
Billings
in excess of cost and earnings
|
46,223,000
|
15,705,000
|
|||||
Current
portion of long-term debt
|
2,584,000
|
2,586,000
|
|||||
TOTAL
CURRENT LIABILITIES
|
88,695,000
|
68,419,000
|
|||||
Deferred
income tax liability
|
495,000
|
1,471,000
|
|||||
Other
liabilities
|
21,000
|
14,000
|
|||||
Long-term
debt
|
5,423,000
|
6,715,000
|
|||||
TOTAL
LIABILITIES
|
94,634,000
|
76,619,000
|
|||||
STOCKHOLDERS'
EQUITY
|
|||||||
Preferred
stock, par value $0.10 per share; 500,000 shares
authorized;
|
|||||||
no
shares issued and outstanding
|
-
|
-
|
|||||
Common
stock, par value $0.15 per share;
|
|||||||
30,000,000
shares authorized; 11,097,245 shares
|
|||||||
issued
and 11,094,012 shares outstanding
|
|||||||
at
7/31/2007 and 1/31/2007
|
1,664,000
|
1,664,000
|
|||||
Warrants
outstanding
|
849,000
|
849,000
|
|||||
Additional
paid-in capital
|
57,285,000
|
57,190,000
|
|||||
Accumulated
other comprehensive loss
|
(13,000
|
)
|
(8,000
|
)
|
|||
Accumulated
deficit
|
(15,832,000
|
)
|
(15,151,000
|
)
|
|||
Treasury
stock at cost; 3,233 shares at 7/31/2007 and 1/31/2007
|
(33,000
|
)
|
(33,000
|
)
|
|||
TOTAL
STOCKHOLDERS' EQUITY
|
43,920,000
|
44,511,000
|
|||||
TOTAL
LIABILITIES AND STOCKHOLDERS' EQUITY
|
$
|
138,554,000
|
$
|
121,130,000
|
Three
months ended July 31,
|
Six
months ended July 31,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
|||||||||||||
Power
industry services
|
$
|
45,599,000
|
$
|
-
|
$
|
88,953,000
|
$
|
-
|
|||||
Nutraceutical
products
|
5,036,000
|
5,211,000
|
9,985,000
|
11,040,000
|
|||||||||
Telecom
infrastructure services
|
2,502,000
|
3,349,000
|
4,631,000
|
6,482,000
|
|||||||||
Net
Sales
|
53,137,000
|
8,560,000
|
103,569,000
|
17,522,000
|
|||||||||
Cost
of sales
|
|||||||||||||
Power
industry services
|
40,590,000
|
-
|
83,835,000
|
-
|
|||||||||
Nutraceutical
products
|
4,122,000
|
3,940,000
|
8,288,000
|
8,326,000
|
|||||||||
Telecom
infrastructure services
|
1,858,000
|
2,678,000
|
3,701,000
|
5,001,000
|
|||||||||
Gross
profit
|
6,567,000
|
1,942,000
|
7,745,000
|
4,195,000
|
|||||||||
Selling,
general and administrative expenses
|
4,773,000
|
1,944,000
|
9,334,000
|
3,920,000
|
|||||||||
(Loss)
income from operations
|
1,794,000
|
(2,000
|
)
|
(1,589,000
|
)
|
275,000
|
|||||||
Interest
expense and amortization of
|
|||||||||||||
subordinated
debt issuance costs
|
181,000
|
216,000
|
385,000
|
477,000
|
|||||||||
Interest
Income
|
(653,000
|
)
|
(1,000
|
)
|
(1,286,000
|
)
|
(3,000
|
)
|
|||||
(Loss)
income from operations before
|
|||||||||||||
income
taxes
|
2,266,000
|
(217,000
|
)
|
(688,000
|
)
|
(199,000
|
)
|
||||||
Income
tax benefit (expense)
|
(932,000
|
)
|
62,000
|
7,000
|
26,000
|
||||||||
Net
income (loss)
|
$
|
1,334,000
|
$
|
(155,000
|
)
|
$
|
(681,000
|
)
|
$
|
(173,000
|
)
|
||
Earnings
per share:
|
|||||||||||||
Basic
earnings per share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Diluted
earnings per share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Weighted
average number of shares:
|
|||||||||||||
Basic
|
11,094,000
|
4,549,000
|
11,094,000
|
4,179,000
|
|||||||||
Diluted
|
11,196,000
|
4,549,000
|
11,094,000
|
4,179,000
|
Six
Months ended July 31,
|
|||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
loss
|
$
|
(681,000
|
)
|
$
|
(173,000
|
)
|
|
Adjustments
to reconcile net loss to net cash provided by operating
activities:
|
|||||||
Depreciation
and other amortization
|
644,000
|
518,000
|
|||||
Amortization
of debt issuance costs
|
-
|
257,000
|
|||||
Amortization
of purchased intangibles
|
4,089,000
|
660,000
|
|||||
Deferred
income taxes
|
(1,411,000
|
)
|
(246,000
|
)
|
|||
Non-cash
stock option compensation expense
|
100,000
|
80,000
|
|||||
Gain
on sale of property and equipment
|
9,000
|
8,000
|
|||||
Gain
on sale of investments
|
11,000
|
-
|
|||||
Changes
in operating assets and liabilities:
|
|||||||
Accounts
receivable, net
|
(7,212,000
|
)
|
(537,000
|
)
|
|||
Restricted
cash for surety bond
|
(3,000
|
)
|
-
|
||||
Estimated
earnings in excess of billings
|
8,084,000
|
94,000
|
|||||
Inventories,
net
|
(55,000
|
)
|
543,000
|
||||
Prepaid
expenses and other current assets
|
(869,000
|
)
|
(337,000
|
)
|
|||
Accounts
payable and accrued expenses
|
(10,307,000
|
)
|
164,000
|
||||
Billings
in excess of cost and earnings
|
30,518,000
|
7,000
|
|||||
Due
from affiliates
|
(7,000
|
)
|
(99,000
|
)
|
|||
Estimated
loss on uncompleted contracts
|
74,000
|
-
|
|||||
Other
|
(9,000
|
)
|
14,000
|
||||
Net
cash provided by operating activities
|
22,975,000
|
953,000
|
|||||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Proceeds
from sale of investments
|
2,272,000
|
-
|
|||||
Proceeds
from sale of property and equipment
|
18,000
|
4,000
|
|||||
Purchases
of property and equipment
|
(224,000
|
)
|
(612,000
|
)
|
|||
Net
cash provided by (used in) investing activities
|
2,066,000
|
(608,000
|
)
|
||||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Net
proceeds from sale of stock
|
-
|
1,863,000
|
|||||
Proceeds
from debt
|
3,292,000
|
2,855,000
|
|||||
Principal
payments on debt
|
(4,586,000
|
)
|
(3,107,000
|
)
|
|||
Principal
payments on subordinated note due former owner of
|
|||||||
Vitarich
Laboratories, Inc.
|
-
|
(1,800,000
|
)
|
||||
Net
cash (used in) provided by financing activities
|
(1,294,000
|
)
|
1,611,000
|
||||
NET
INCREASE IN CASH AND CASH EQUIVALENTS
|
23,747,000
|
1,956,000
|
|||||
CASH
AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
|
25,393,000
|
5,000
|
|||||
CASH
AND CASH EQUIVALENTS AT END OF PERIOD
|
$
|
49,140,000
|
$
|
1,961,000
|
|||
SUPPLEMENTAL
CASH FLOW INFORMATION
|
|||||||
Cash
paid for interest and income taxes is as follows:
|
|||||||
Interest
|
$
|
729,000
|
$
|
128,000
|
|||
Income
taxes
|
$
|
2,700,000
|
$
|
8,000
|
|||
Non-cash
investing and financing activities are as follows:
|
|||||||
Net
increase in fair value of interest rate swaps
|
$
|
9,000
|
$
|
-
|
July
31,
2007
|
January
31,
2007
|
||||||
Raw
materials
|
$
|
2,285,000
|
$
|
2,264,000
|
|||
Work-in
process
|
145,000 | 100,000 | |||||
Finished
goods
|
155,000 | 127,000 | |||||
Less:
Reserves
|
(143,000 | ) | (104,000 | ) | |||
Inventories,
net
|
$
|
2,442,000
|
$
|
2,387,000
|
Estimated
Useful Life
|
Gross
Carrying Amount
|
Accumulated
Amortization
|
Net
Carrying
Amount
|
||||||||||
Intangible
Assets Being
Amortized:
|
|||||||||||||
Contractual
Customer
Relationships
- VLI & SMC
|
5-7
years
|
$
|
2,854,000
|
$
|
1,715,000
|
$
|
1,139,000
|
||||||
Customer
Relationships - GPS
|
1-2
years
|
6,678,000
|
4,209,000
|
2,469,000
|
|||||||||
Proprietary
Formulas - VLI
|
3
years
|
1,813,000
|
1,775,000
|
38,000
|
|||||||||
Non-Compete
Agreement -
GPS
& VLI
|
5
years
|
2,334,000
|
1,118,000
|
1,216,000
|
|||||||||
Trade
Name - GPS
|
15
years
|
3,643,000
|
157,000
|
3,486,000
|
|||||||||
Intangible
Assets Not Being
Amortized:
|
|
||||||||||||
Trade
Name - SMC
|
Indefinite
|
224,000
|
—
|
224,000
|
|||||||||
Total
other intangible assets
|
$
|
17,546,000
|
$
|
8,974,000
|
$
|
8,572,000
|
|||||||
Goodwill
|
Indefinite
|
$
|
23,981,000
|
$
|
—
|
$
|
23,981,000
|
2007
|
2006
|
||||||
Computed
“expected” tax benefit
|
$
|
234,000
|
$
|
68,000
|
|||
Increase
(decrease) resulting from:
|
|||||||
State
income taxes, net
|
(203,000
|
)
|
(16,000
|
)
|
|||
Permanent
differences
|
(24,000
|
)
|
(26,000
|
)
|
|||
|
$
|
7,000
|
$
|
26,000
|
Six
Months Ended July 31,
|
|||||||
2007
|
2006
|
||||||
Dividend
yield
|
—
|
—
|
|||||
Expected
volatility
|
71
|
%
|
57
|
%
|
|||
Risk-free
interest rate
|
4.85
|
%
|
5.11
|
%
|
|||
Expected
life in years
|
5
|
5
|
Options
|
Shares
|
Weighted-
Average
Exercise
Price
|
Weighted-
Average
Remaining
Contract
Term
|
Aggregate
Intrinsic
Value
|
|||||||||
Outstanding
at January 31, 2007
|
244,000
|
$
|
4.20
|
||||||||||
Granted
|
107,000
|
$
|
6.27
|
||||||||||
Exercised
|
—
|
||||||||||||
Forfeited
or expired
|
(3,000
|
)
|
$
|
7.79
|
|||||||||
Outstanding
at July 31, 2007
|
348,000
|
$
|
4.81
|
5.7
|
$
|
962,000
|
|||||||
Vested
or expected to vest
July
31, 2007
|
348,000
|
$
|
4.81
|
5.7
|
$
|
962,000
|
|||||||
Exercisable
at July 31, 2007
|
225,000
|
$
|
4.05
|
7.7
|
$
|
411,000
|
Shares
|
Aggregate
Intrinsic
Value
|
||||||
Nonvested
at January 31, 2007
|
16,000
|
||||||
Granted
|
107,000
|
||||||
Vested
|
—
|
||||||
Forfeited
|
—
|
||||||
Nonvested
at July 31, 2007
|
123,000
|
$
|
4.50
|
Three months ended July 31, |
Six
months ended July 31,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
Income (Loss)
|
$
|
1,334,000
|
$
|
(155,000
|
)
|
$
|
(681,000
|
)
|
$
|
(173,000
|
)
|
||
Weighted
average number of
shares
outstanding - basic
|
11,094,000
|
4,549,000
|
11,094,000
|
4,179,000
|
|||||||||
Effect
of the increase of stock
options
and warrants
|
102,000
|
-
|
-
|
-
|
|||||||||
Weighted
average number of
shares
outstanding - diluted
|
11,196,000
|
4,549,000
|
11,094,000
|
4,179,000
|
|||||||||
Basic
Income (Loss) Per Share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Diluted
Income (Loss) Per Share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Shares
excluded from the
computation
of diluted weighted
average
number of shares, since
their
inclusion would be
anti-dilutive
|
-
|
4,000
|
100,000
|
2,000
|
Power
Industry Services
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||||
Net
sales
|
$
|
45,599,000
|
$
|
5,036,000
|
$
|
2,502,000
|
—
|
$
|
53,137,000
|
|||||||
Cost
of sales
|
40,590,000
|
4,122,000
|
1,858,000
|
—
|
46,570,000
|
|||||||||||
Gross
profit
|
5,009,000
|
914,000
|
644,000
|
—
|
6,567,000
|
|||||||||||
Selling,
general and administrative
expenses
|
2,553,000
|
1,015,000
|
340,000
|
865,000
|
4,773,000
|
|||||||||||
Income
(loss) from operations
|
2,456,000
|
(101,000
|
)
|
304,000
|
(865,000
|
)
|
1,794,000
|
|||||||||
Interest
expense
|
(149,000
|
)
|
(141,000
|
)
|
(7,000
|
)
|
116,000
|
(181,000
|
)
|
|||||||
Other
income, net
|
722,000
|
—
|
10,000
|
(79,000
|
)
|
653,000
|
||||||||||
Income
(loss) before income
taxes
|
$
|
3,029,000
|
$
|
(242,000
|
)
|
$
|
307,000
|
$
|
(828,000
|
)
|
2,266,000
|
|||||
Income
tax expense
|
932,000
|
|||||||||||||||
Net
Income
|
$
|
1,334,000
|
||||||||||||||
Depreciation
and amortization
|
$
|
41,000
|
$
|
149,000
|
$
|
126,000
|
$
|
4,000
|
$
|
320,000
|
||||||
Amortization
of intangibles
|
$
|
1,695,000
|
$
|
304,000
|
$
|
26,000
|
—
|
$
|
2,025,000
|
|||||||
Goodwill
|
$
|
16,476,000
|
$
|
6,565,000
|
$
|
940,000
|
—
|
$
|
23,981,000
|
|||||||
Total
Assets
|
$
|
116,531,000
|
$
|
14,850,000
|
$
|
4,484,000
|
$
|
2,689,000
|
$
|
138,554,000
|
||||||
Fixed
asset
additions
|
—
|
$
|
39,000
|
$
|
85,000
|
—
|
$
|
124,000
|
Power
Industry Services
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||||
Net
sales
|
$
|
88,953,000
|
$
|
9,985,000
|
$
|
4,631,000
|
—
|
$
|
103,569,000
|
|||||||
Cost
of sales
|
83,835,000
|
8,288,000
|
3,701,000
|
95,824,000
|
||||||||||||
Gross
profit
|
5,118,000
|
1,697,000
|
930,000
|
7,745,000
|
||||||||||||
Selling,
general and administrative
expenses
|
5,105,000
|
2,185,000
|
698,000
|
1,346,000
|
9,334,000
|
|||||||||||
(Loss)
income from operations
|
13,000
|
(488,000
|
)
|
232,000
|
(1,346,000
|
)
|
(1,589,000
|
)
|
||||||||
Interest
expense
|
(316,000
|
)
|
(176,000
|
)
|
(9,000
|
)
|
116,000
|
(385,000
|
)
|
|||||||
Other
income, net
|
1,348,000
|
—
|
10,000
|
(72,000
|
)
|
1,286,000
|
||||||||||
(Loss)
income before income
taxes
|
$
|
1,045,000
|
$
|
(664,000
|
)
|
$
|
233,000
|
$
|
(1,302,000
|
)
|
(688,000
|
)
|
||||
Income
tax benefit
|
7,000
|
|||||||||||||||
Net
loss
|
($681,000
|
)
|
||||||||||||||
Depreciation
and amortization
|
$
|
94,000
|
$
|
293,000
|
$
|
249,000
|
$
|
8,000
|
$
|
644,000
|
||||||
Amortization
of intangibles
|
$
|
3,428,000
|
$
|
609,000
|
$
|
52,000
|
—
|
$
|
4,089,000
|
|||||||
Goodwill
|
$
|
16,476,000
|
$
|
6,565,000
|
$
|
940,000
|
—
|
$
|
23,981,000
|
|||||||
Total
Assets
|
$
|
116,531,000
|
$
|
14,850,000
|
$
|
4,484,000
|
$
|
2,689,000
|
$
|
138,554,000
|
||||||
Fixed
asset additions
|
$
|
4,000
|
$
|
124,000
|
$
|
96,000
|
—
|
$
|
224,000
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||
Net
sales
|
$
|
5,211,000
|
$
|
3,349,000
|
$
|
—
|
$
|
8,560,000
|
|||||
Cost
of sales
|
3,940,000
|
2,678,000
|
—
|
6,618,000
|
|||||||||
Gross
profit
|
1,271,000
|
671,000
|
—
|
1,942,000
|
|||||||||
Selling,
general and administrative expenses
|
1,070,000
|
424,000
|
450,000
|
1,944,000
|
|||||||||
Income
(loss) from operations
|
201,000
|
247,000
|
(450,000
|
)
|
(2,000
|
)
|
|||||||
Interest
expense and amortization of
subordinated debt issuance costs
|
81,000
|
10,000
|
125,000
|
216,000
|
|||||||||
Other
income, net
|
—
|
1,000
|
—
|
1,000
|
|||||||||
Income
(loss) before income taxes
|
$
|
120,000
|
$
|
238,000
|
$
|
(575,000
|
)
|
(217,000
|
)
|
||||
Income
tax benefit
|
62,000
|
||||||||||||
Net
loss
|
$
|
(155,000
|
)
|
||||||||||
Depreciation
and amortization
|
$
|
139,000
|
$
|
119,000
|
$
|
141,000
|
$
|
399,000
|
|||||
Amortization
of intangibles
|
$
|
304,000
|
$
|
25,000
|
$
|
—
|
$
|
329,000
|
|||||
Goodwill
|
$
|
6,565,000
|
$
|
940,000
|
$
|
—
|
$
|
7,505,000
|
|||||
Total
assets
|
$
|
17,315,000
|
$
|
5,427,000
|
$
|
418,000
|
$
|
23,160,000
|
|||||
Fixed
asset additions
|
$
|
93,000
|
$
|
238,000
|
$
|
8,000
|
$
|
339,000
|
Nutraceutical
Products
|
Telecom
Infrastructure
Services
|
Other
|
Consolidated
|
||||||||||
Net
sales
|
$
|
11,040,000
|
$
|
6,482,000
|
$
|
—
|
$
|
17,522,000
|
|||||
Cost
of sales
|
8,326,000
|
5,001,000
|
—
|
13,327,000
|
|||||||||
Gross
profit
|
2,714,000
|
1,481,000
|
—
|
4,195,000
|
|||||||||
Selling,
general and administrative expenses
|
2,157,000
|
838,000
|
925,000
|
3,920,000
|
|||||||||
Income
(loss) from operations
|
557,000
|
643,000
|
(925,000
|
)
|
275,000
|
||||||||
Interest
expense and amortization of
subordinated debt issuance costs
|
208,000
|
29,000
|
240,000
|
477,000
|
|||||||||
Other
income, net
|
—
|
3,000
|
—
|
3,000
|
|||||||||
Income
(loss) before income taxes
|
$
|
349,000
|
$
|
617,000
|
$
|
(1,165,000
|
)
|
(199,000
|
)
|
||||
Income
tax benefit
|
26,000
|
||||||||||||
Net
loss
|
$
|
(173,000
|
)
|
||||||||||
Depreciation
and amortization
|
$
|
273,000
|
$
|
231,000
|
$
|
271,000
|
$
|
775,000
|
|||||
Amortization
of intangibles
|
$
|
609,000
|
$
|
51,000
|
$
|
$
—
|
$
|
660,000
|
|||||
Goodwill
|
$
|
6,565,000
|
$
|
940,000
|
$
|
$
—
|
$
|
7,505,000
|
|||||
Total
assets
|
$
|
17,315,000
|
$
|
5,427,000
|
$
|
418,000
|
$
|
23,160,000
|
|||||
Fixed
asset additions
|
$
|
189,000
|
$
|
415,000
|
$
|
8,000
|
$
|
612,000
|
|
•
|
|
cyclical
changes in demand for our products and services;
|
|
•
|
|
cyclical
nature of the individual markets in which our customers
operate;
|
|
•
|
|
That
the dollar amount of our backlog, as stated at any given time, is
not
indicative of our future earnings;
|
|
•
|
|
delays
or difficulties related to our projects including additional costs,
reductions in revenues or the payment of liquidated
damages;
|
|
•
|
|
the
effect of our percentage-of-completion accounting
policies;
|
|
•
|
|
changes
in the estimates and assumptions we use to prepare our financial
statements;
|
|
•
|
|
our
ability to obtain surety bonds or other means of credit support for
projects;
|
|
•
|
|
our
ability to obtain waivers or amendments with our lenders or sureties,
or
to collateralize letters of credit or surety bonds upon non-compliance
with covenants in our Credit Facility or surety indemnity
agreements;
|
|
•
|
|
compliance
with certain debt covenants, which as a result, may interfere with
our
ability to successfully execute our business plan;
|
|
•
|
|
our
indebtedness, which could adversely affect our financial condition
and
impair our ability to fulfill our obligations under our financing
arrangements;
|
|
•
|
|
various
legal, regulatory and litigation risk including but not limited to,
class
action lawsuits, regulatory activities and associated periodic reviews
of
the SEC and Public Company Accounting Oversight
Board;
|
|
•
|
|
the
nature of our contracts, particularly fixed-price
contracts;
|
|
•
|
|
the
failure to meet schedule or performance requirements of our
contracts;
|
|
•
|
|
our
dependence on subcontractors;
|
|
•
|
|
possible
cost escalations associated with our fixed-price
contracts;
|
|
•
|
|
our
ability to obtain new contracts for large-scale projects and the
timing of
the performance of these contracts;
|
|
•
|
|
The
effect on our reputation and financial exposure due to the failure
of our
partners to perform their contractual obligations;
|
|
•
|
|
our
dependence on a few significant customers;
|
|
•
|
|
delays
and/or defaults in customer payments;
|
|
•
|
|
potential
professional liability, product liability, warranty and other potential
claims, which may not be covered by insurance;
|
|
•
|
|
the
presence of competitors with greater financial resources and the
impact of
competitive products, services and pricing;
|
|
•
|
|
work
stoppages and other labor problems;
|
|
•
|
|
our
liquidity position;
|
|
•
|
|
a
determination to write-off a significant amount of our intangible
assets;
|
|
•
|
|
our
ability to successfully identify, integrate and complete
acquisitions;
|
|
•
|
|
our
failure to attract and retain qualified personnel;
|
|
•
|
|
our
ability to retain key members of our management;
|
|
•
|
|
our
competitors’ ability to develop or otherwise acquire equivalent or
superior technology;
|
|
•
|
|
general
economic conditions;
|
|
•
|
|
future
changes in accounting standards or interpretations;
|
|
•
|
|
inability
to maintain an effective system of internal control, which could
result in
inaccurate reporting of our financial results or an inability to
prevent
fraud;
|
|
•
|
|
provisions
in our articles of incorporation and by-laws and rights agreement
could
make it more difficult to acquire us and may reduce the market price
of
our common stock;
|
|
•
|
|
changes
in the U.S. economy and global markets as a result of terrorists’
actions;
|
|
•
|
|
increases
in employee-related costs and expenses including healthcare and other
employee benefits such as unemployment insurance and workers’
compensation; and
|
|
•
|
|
our
dependency on technology in our operations and the possible impact
of
system and information technology
interruptions.
|
Three
months ended July 31,
|
Six
months ended July 31,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
|||||||||||||
Power
industry services
|
$
|
45,599,000
|
$
|
-
|
$
|
88,953,000
|
$
|
-
|
|||||
Nutraceutical
products
|
5,036,000
|
5,211,000
|
9,985,000
|
11,040,000
|
|||||||||
Telecom
infrastructure services
|
2,502,000
|
3,349,000
|
4,631,000
|
6,482,000
|
|||||||||
Net
Sales
|
53,137,000
|
8,560,000
|
103,569,000
|
17,522,000
|
|||||||||
Cost
of sales
|
|||||||||||||
Power
industry services
|
40,590,000
|
-
|
83,835,000
|
-
|
|||||||||
Nutraceutical
products
|
4,122,000
|
3,940,000
|
8,288,000
|
8,326,000
|
|||||||||
Telecom
infrastructure services
|
1,858,000
|
2,678,000
|
3,701,000
|
5,001,000
|
|||||||||
Gross
profit
|
6,567,000
|
1,942,000
|
7,745,000
|
4,195,000
|
|||||||||
Selling,
general and administrative expenses
|
4,773,000
|
1,944,000
|
9,334,000
|
3,920,000
|
|||||||||
(Loss)
income from operations
|
1,794,000
|
(2,000
|
)
|
(1,589,000
|
)
|
275,000
|
|||||||
Interest
expense and amortization of
|
|||||||||||||
subordinated
debt issuance costs
|
181,000
|
216,000
|
385,000
|
477,000
|
|||||||||
Interest
Income
|
(653,000
|
)
|
(1,000
|
)
|
(1,286,000
|
)
|
(3,000
|
)
|
|||||
(Loss)
income from operations before
|
|||||||||||||
income
taxes
|
2,266,000
|
(217,000
|
)
|
(688,000
|
)
|
(199,000
|
)
|
||||||
Income
tax benefit (expense)
|
(932,000
|
)
|
62,000
|
7,000
|
26,000
|
||||||||
Net
income (loss)
|
$
|
1,334,000
|
$
|
(155,000
|
)
|
$
|
(681,000
|
)
|
$
|
(173,000
|
)
|
||
Earnings
per share:
|
|||||||||||||
Basic
earnings per share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Diluted
earnings per share
|
$
|
0.12
|
$
|
(0.03
|
)
|
$
|
(0.06
|
)
|
$
|
(0.04
|
)
|
||
Weighted
average number of shares:
|
|||||||||||||
Basic
|
11,094,000
|
4,549,000
|
11,094,000
|
4,179,000
|
|||||||||
Diluted
|
11,196,000
|
4,549,000
|
11,094,000
|
4,179,000
|
2007
|
2006
|
||||||
Computed
“expected” tax benefit
|
$
|
234,000
|
$
|
68,000
|
|||
Increase
(decrease) resulting from:
|
|||||||
State
income taxes, net
|
(203,000
|
)
|
(16,000
|
)
|
|||
Permanent
differences
|
(24,000
|
)
|
(26,000
|
)
|
|||
|
$
|
7,000
|
$
|
26,000
|
Three
months ended July 31,
|
Six
months ended July 31,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Net
sales
|
|||||||||||||
Power
industry services
|
$
|
45,599,000
|
$
|
22,393,000
|
$
|
88,953,000
|
$
|
37,627,000
|
|||||
Nutraceutical
products
|
5,036,000
|
5,211,000
|
9,985,000
|
11,040,000
|
|||||||||
Telecom
infrastructure services
|
2,502,000
|
3,349,000
|
4,631,000
|
6,482,000
|
|||||||||
Net
sales
|
53,137,000
|
30,953,000
|
103,569,000
|
55,149,000
|
|||||||||
Cost
of sales
|
|||||||||||||
Power
industry services
|
40,590,000
|
20,171,000
|
83,835,000
|
35,229,000
|
|||||||||
Nutraceutical
products
|
4,122,000
|
3,940,000
|
8,288,000
|
8,326,000
|
|||||||||
Telecom
infrastructure services
|
1,858,000
|
2,678,000
|
3,701,000
|
5,001,000
|
|||||||||
Gross
profit
|
6,567,000
|
4,164,000
|
7,745,000
|
6,593,000
|
|||||||||
Selling
and general and administrative expenses
|
4,773,000
|
2,686,000
|
9,334,000
|
5,369,000
|
|||||||||
(Loss)
income from operations
|
$
|
1,794,000
|
$
|
1,478,000
|
$
|
(1,589,000
|
)
|
$
|
1,224,000
|
Six months ended July 31, | |||||||
2007
|
2006
|
||||||
Net
loss, as reported
|
$
|
(681,000
|
)
|
$
|
(173,000
|
)
|
|
Interest
expense and amortization of Subordinated
debt issuance costs
|
385,000
|
477,000
|
|||||
Tax
benefit
|
(7,000
|
)
|
(26,000
|
)
|
|||
Depreciation
and amortization
|
644,000
|
518,000
|
|||||
Amortization
of intangible assets
|
4,089,000
|
660,000
|
|||||
EBITDA
|
$
|
4,430,000
|
$
|
1,456,000
|
Exhibit
No.
|
Title
|
|
Exhibit:
31.1
|
Certification
of Chief Executive Officer, pursuant to Rule 13a-14(c)
under the Securities Exchange Act of 1934
|
|
|
||
Exhibit:
31.2
|
Certification
of Chief Financial Officer, pursuant to Rule 13a-14(c)
under the Securities Exchange Act of 1934
|
|
Exhibit:
32.1
|
Certification
of Chief Executive Officer, pursuant to 18
U.S.C. Section 1350
|
|
Exhibit:
32.2
|
Certification
of Chief Financial Officer, pursuant to 18
U.S.C. Section 1350
|
ARGAN, INC. | ||
|
|
|
September
12, 2007
|
By: | /s/ Rainer Bosselmann |
Rainer
Bosselmann
Chairman
of the Board and Chief Executive Officer
|
||
September
12, 2007
|
By: | /s/ Arthur F. Trudel |
Arthur
F. Trudel
Senior
Vice President, Chief Financial Officer and Secretary
|
||